Compare Johnson & Johnson (JNJ) vs ProShares UltraPro Short QQQ ETF (SQQQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs ProShares UltraPro Short QQQ ETF — how do they compare? Johnson & Johnson trades at $253.1 (market cap $609.12B), while ProShares UltraPro Short QQQ ETF trades at $41.58. The key difference: Johnson & Johnson pays a 2.12% dividend while ProShares UltraPro Short QQQ ETF pays none, and Johnson & Johnson is trading nearer its 52-week high, ProShares UltraPro Short QQQ ETF nearer its low. Which is the better fit depends on your goals.
| JNJ | SQQQ | |
|---|---|---|
Market Cap | $609.12B | — |
Volume | 6,156,228 | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $267.24 | $97.60 |
52-Week Low | $163.70 | $36.31 |
Enterprise Value | $642.06B | — |
Dividend Yield | 2.12% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $253.04, up 1.23% today, with a bullish technical signal from moving averages and strong earnings beats in Q1 and Q2 2026. The company raised 2026 guidance, with revenue projected to exceed $100 billion, supported by robust profitability margins and a solid dividend track record. Recent news highlights institutional buying and analyst optimism following Q2 results.
Outlook remains positive with a consensus price target of $279.33, offering ~10% upside. Key risks include MedTech segment volatility and rising debt levels, but JNJ's diversified healthcare portfolio and AAA balance sheet provide stability for long-term investors amid market fluctuations.
SQQQ trades at $42.79, up 4.65% today with a bullish technical signal from moving averages. The ETF serves as a tactical hedging tool against Nasdaq 100 declines through 3x daily inverse leverage. Recent news highlights its high-risk nature and long-term erosion due to daily resets, with Seeking Alpha noting its unsuitability as a long-term investment. The current neutral oscillator reading suggests limited momentum despite the bullish trend indicators.
SQQQ's outlook remains highly speculative with significant decay risk from daily leverage resets. It offers tactical hedging potential during market downturns but carries substantial volatility. Investors should recognize this as a short-term instrument rather than a core holding, with success dependent on precise timing amid ongoing tech sector strength.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About ProShares UltraPro Short QQQ ETF
SQQQ is a leveraged inverse ETF that seeks daily investment results, before fees and expenses, that correspond to three times the inverse (-3x) of the daily performance of the Nasdaq-100 Index. It is a tactical trading tool designed for sophisticated investors to profit from or hedge against declines in large-cap technology and growth stocks. Due to its daily reset and the effects of compounding, it is intended for short-term use and carries significant risk if held during periods of high market volatility.
Read more on SQQQ →
